This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tokyo Medical and Dental University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Tomomi Aida: Innovator in Genetic Modification
Introduction
Tomomi Aida is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of genetic engineering, particularly in the production of genetically modified non-human mammals. Her innovative methods utilize advanced technologies to enhance efficiency in genetic modifications.
Latest Patents
Aida holds a patent for a method of conveniently producing genetically modified non-human mammals with high efficiency. This patent, titled "Method of conveniently producing genetically modified non-human mammal with high efficiency," focuses on utilizing the CRISPR-Cas9 system. The invention aims to provide a streamlined approach to gene knock-in, achieving high efficiency regardless of gene size. The method involves introducing a Cas9 protein, a crRNA fragment, and a tracrRNA fragment into a non-human mammalian oocyte to facilitate genetic modification.
Career Highlights
Tomomi Aida is affiliated with the Tokyo Medical and Dental University, where she conducts her research and development. Her work has garnered attention for its potential applications in biotechnology and medicine. Aida's innovative approach has positioned her as a key figure in the field of genetic modification.
Collaborations
Aida collaborates with notable colleagues, including Kohichi Tanaka and Yusaku Wada. These partnerships enhance her research efforts and contribute to the advancement of genetic engineering techniques.
Conclusion
Tomomi Aida's contributions to genetic modification through her innovative patent demonstrate her commitment to advancing scientific knowledge. Her work not only showcases her expertise but also holds promise for future developments in biotechnology.